News

GlaxoSmithKline has teamed up with Xiamen Innovax Biotech to evaluate a vaccine against the novel coronavirus behind the COVID-19 pandemic. The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based...

Ergomed plc , a company focused on providing specialised services to the pharmaceutical industry, announces it is providing support for a clinical development programme for namilumab, a monoclonal antibody therapy targeting granulocyte-macrophage colony stimulating factor (GM-CSF), for the treatment...

Gilead Sciences has been ramping up production of its experimental remdesivir treatment that is being tested to combat the novel coronavirus. The drug maker now has 1.5 million individual dosages that could be used for more than 140,000 patients and...

Mondi is committed to playing its part to produce important supplies and components during the COVID-19 outbreak. As a global leader in packaging and paper, Mondi’s Personal Care Components team has found a way to convert a production line...

Accord will donate the tablets, along with the same number of matched placebo, to the global COPCOV study. The study is assessing the use of chloroquine and hydroxychloroquine in the prevention of Covid-19 in healthcare settings. The study involves...

Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK diagnostic testing laboratories and facilities in the coming weeks and months. The portal enables scientists...

N4 Pharma Plc , the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces that it will be undertaking a proof of concept research project using a Covid-19 DNA plasmid for the purpose...